Polymorphisms of the renin-angiotensin system genes in progressive renal diseases

Kidney International

Volumn 50, Issue 3, 1996, Pages 732-744

  Yoshida, Hiroaki ^b   Kon, Valentina ^b   Ichikawa, Iekuni ^a  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

DISEASE COURSE; DNA POLYMORPHISM; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0029763464     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.371     Document Type: Editorial

References (137)

1. GELEHRTER TD, COLLINS FS: Principles of Medical Genetics. Baltimore, Williams & Wilkins, 1990, pp 299-312
2. HIKI Y, KOBAYASHI Y, ITOH I, KASHIWAGI N: Strong association of HLA-DR2 and MT1 with idiopathic membranous nephropathy in Japan. Kidney Int 25:953-967, 1984
3. KLOUDA PT, MANOS J, ACHESON EJ, DYER PA, GOLDBY FS, HARRIS R, LAWLER W, MALLICK NP, WILLIAMS G: Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet 2:770-771, 1979
4. LE PETIT JC, LAURENT B, BERTHOUX FC: HLA-DR3 and idiopathic membranous nephritis (IMN) association. Tissue Antigens 20:227-228, 1982
5. MULLER GA, MULLER C, LIEBAU S, KOMPF J, ISING H, WERNET P: Strong association of idiopathic membranous nephropathy (IMN) with HLA-DR3 and MT-2 without involvement of HLA-B18 and no association to Bf F1. Tissue Antigens 17:332-337, 1981
6. EGIDO J, JULIAN BA, WYATT RJ: Genetic factors in primary IgA nephropathy. Nephrol Dial Transplant 2:134-142. 1987
7. WELCH TR, BERRY A, BEISCHEL LS: C4 isotype deficiency in IgA nephropathy. Pediatr Nephrol 1:136-139, 1987
8. WYATT RJ, JULIAN BA, WOODFORD SY, WANG C, ROBERTS J, THOMPSON JS, CHRISTENSON MJ, MCLEAN RH: C4A deficiency and poor prognosis in patients with IgA nephropathy. Clin Nephrol 36:1-5, 1991
9. POWIS SJ, DEVERSON EV, COADWELL WJ: Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature 357:211-215, 1992
10. CHEVRIER D, GIRAL M, BRAUD V, SOULILLOU JP, BIGNON JD: Membranous nephropathy and a tap1 gene polymorphism. N Engl J Med 331:133-134, 1994
11. BEUTLER B, CERAMI A: The biology of cachectin/TNF-A primary mediator of the host response. Ann Rev Immunol 7:625-655, 1989
12. BLAKEMORE AIF, TARLOW JK, CORK MJ, GORDON C, EMERY P, DUFF GW: Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthr Rheum 37:1380-1385, 1994
13. WILSON AG, DI GIOVINE FS, BLAKEMORE AI, DUFF GW: Single base polymorphism in the human tumour necrosis factor alpha (TNFα) gene detectable by Ncol restriction of PCR product. (abstract) Hum Mol Genet 1:353, 1992
14. WILSON AG, DUFF GW: Genetic traits in common diseases. Brit Med J 310:1482-1483, 1995
15. MEDCRAFT J, HITMAN GA, SACHS JA, WHICHELOW CE, RAAFAT I, MOORE RH: Autoimmune renal disease and tumour necrosis factor β gene polymorphism. Clin Nephrol 40:63-68, 1993
16. VAN HEYNINGEN V, HASTIE ND: Wilms' tumour: Reconciling genetics and biology. Trend Genet 8:16-21, 1992
17. UHL G, BLUM K, NOBLE E, SMITH S: Substance abuse vulnerability and D2 receptor genes. Trend Neurosci 16:83-88, 1993
18. OLMOS P, A'HERN R, HEATON DA, MILLWARD BA, RISLEY D, PYKE DA, LESLIE RD: The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 31:747-750, 1988
19. HILBERT P, LINDPAINTNER K, BECKMANN JS, SERIKAWA T, SOUBRIER R, DUBAY C, CARTWRIGHT P, DE GOUYON B, JULIER C, TAKAHASHI S, VINCENT M, GANTEN D, GEORGES M, LATHROP GM: Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature 353:521-529, 1991
20. LIFTON RP: Genetic determinants of human hypertension. Proc Natl Acad Sci USA 92:8545-8551, 1995
21. THIBONNIER M, SCHORK NJ: The genetics of hypertension. Curr Opin Genet Dev 5:362-370, 1995
22. COHN JN, JOHNSON G, ZIESCHE S, COBB F, FRANCIS G, TRISTANI F, SMITH R, DUNKMAN WB, LOEB H, WONG M, ET AL: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325:303-310, 1991
23. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
24. CATTRAN DC, GREENWOOD C, RITCHIE S: Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 23:247-254, 1994
25. LINZ W, SCHØLKENS BA, GANTEN D: Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens 11:1325-1350, 1989
26. PFEFFER MA, PFEFFER JM, STEINBERG C, FINN P: Survival after an experimental myocardial infarction: Beneficial effects of long-term therapy with captopril. Circulation 72:400-412, 1985
27. ANDERSON S, RENNKL HG, BRENNER BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
28. BRILLA CG, PICK R, TAN LB, JANICKI JS, WEBER KT: Remodeling of the rat right and left ventricle in experimental hypertension. Circ Res 67:1355-1364, 1990
29. FOGO A, YOSHIDA Y, GLICK AD, ICHIKAWA: Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 82:322-330, 1988
30. YOSHIDA Y, FOGO A, GLICK AD, ICHIKAWA I: Serial micropuncture analysis of single nephron function in chronic renal disease. A study in the rat model of subtotal renal ablation. Kidney Int 33:855-867, 1988
31. PAQUET JL, BAUDOUIN-LEGROS M, BRUNELLE G, MEYER P: Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens 8:565-572, 1990
32. NAFTILAN AJ, PRATT RE, DZAU VJ: Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 83:1419-1424, 1989
33. DZAU VJ, GIBBONS GH, PRATT RE: Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension 18(Suppl 4):100-105, 1991
34. BERK BC, VEKSHTEIN V, GORDON HM, TSUDA T: Angiotensin II stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13:305-314, 1989
35. HOMMA T, HOOVER RL, ICHIKAWA I, HARRIS RC: Angiotensin II induces hypertrophy and stimulates collagen production in rat mesangial cell. (abstract) Clin Res 38:358, 1990a
36. WOLF G, HABERSTROH U, NEILSON EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140:95-107, 1992
37. RAY PE, BRUGGEMAN LA, HORIKOSHI S, AGUILERA G, KLOTMAN P: Angiotensin II stimulates human fetal mesangial cell prolifeation and fibronectin biosynthesis by binding to AT1 receptors. Kidney Int 45:177-184, 1994
38. RUIZ-ORTEGA M, GOMEZ-GARRE D, ALCAZAR R, PALACIOS I, BUSTOS C, GONZALFZ S, PLAZA JJ, GONZALEZ E, EGIDO J: Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis. J Hyperten 12(Suppl 4):S51-S58, 1994
39. KAGAMI S, BORDER WA, MILLER DE, NOBLE NA: Angiotensin II stimulates matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
40. WOLF G, MUELLER E, STAHL RA, ZIYADEH FN: Angiotensin II-inducEd hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 92:1366-1372, 1993
41. BRILLA CG, ZHOU G, WEBER KT: Angiotensin II and collagen synthesis in cultured adult rat cardiac fibroblasts. (abstract) J Hypertens 10(Suppl 4):S125, 1992
42. BRILLA CG, MATSUBARA L, WEBER KT: Inhibition of collagenase activity in cultured cardiac fibroblasts by angiotensin II. (abstract) Eur Heart J 1(Suppl):111, 1992
43. NAKAMURA T, TAKAHASHI T, FUKUI M, EBIHARA I, OSADA S, TOMINO Y, KOIDE H: Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J Am Soc Nephrol 5:1492-1497, 1995
44. ARAI M, WADA A, ISAKA Y, AKAGI Y, SUGIURA T, MIYAZAKI M, MORIYAMA T, KANEDA Y, NARUSE K, NARUSE M: In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis. Biochem Biophys Res Comm 206:525-532, 1995
45. BARICOS WH, CORTEZ SL, EL-DAHR SS, SCHNAPER HW: ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 47:1039-1047, 1995
46. VAUGHAN DE, LAZOS SA, TONG K: Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J Clin Invest 95:995-1001, 1995
47. HAMSTEN A, WIMAN B, DEFAIRE U, BLOMBACK M: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1556-1563, 1985
48. HAMSTEN A, WALLDINS G, SZAMOSI A, BLOMBACK M, DEFAIRE U, DAHLEN G, LANDOU C, WIMAN B: Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 2:3-9, 1987
49. RIDKER PM, GABOURY CL, CONLIN PR, SEELY EW, WILLIAMS GH, VAUGHAN DE: Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Circulation 87:1969-1973, 1993
50. VAUGHAN DE, PFEFFER MA: Angiotensin converting enzyme inhibitors and cardiovascular remodeling. Cardivasc Res 28:159-165, 1994
51. FEENER EP, NORTHRUP JM, AIELLO LP, KING GL: Angiotensin II induces plasminogen activator inhibitor-1 and 2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 95:1353-1362, 1995
52. HOSTETTER TH, ROSENBERG ME, KREN S, GREENE E: Aldosterone induces glomerular sclerosis in the remnant kidney. (abstract) J Am Soc Nephrol 6:1016, 1995
53. WEBER KT, BRILLA CG, JANICKI JS, REDDY HK, CAMPBELL SE: Myocardial fibrosis: Role of ventricular systolic pressure, arterial hypertension and circulation hormones. Basic Res Cardiol 86(Suppl 3):25-31, 1991
54. VON LUTTEROTTI N, CATANZARO DF, SEALEY JE, LARAGH JH: Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation 89:458-470, 1994
55. DZAU VJ, RE R: Tissue angiotensin system in cardiovascular medicine: A paradigm shift? Circulation 89:493-498, 1994
56. HOLTZ J, GOETX RM: The endothelium and the renin-angiotensin system. Arzneimittel-Forschung 44:397-402, 1994
57. RAKUGI H, KRIEGER J, WANG DS, DZAU VJ, PRATT RE: Induction of angiotensin converting enzyme in neointima after balloon injury. Circulation 84:(Suppl II):113, 1991
58. SADOSHIMA J, XU Y, SLAYTER HS, IZUMO S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75:977-984, 1993
59. YASUDA T, BECKER B, KONDO S, VAIKUNTH S, HOMMA T, HARRIS RC: Mechanical stretch/relaxation increases type I angiotensin II receptor expression and angiotensinogen mRNA in cultured rat mesangial cells. (abstract) J Am Soc Nephrol 5:554, 1994
60. MIYAZAKI Y, KAWAMURA T, YOSHIDA H, MITARAI T, KOMURO K, YAZAKI Y, ICHIKAWA I, SAKAI O: Static stretch enhances angiotensinogen and angiotensin converting enzyme gene expressions in glomerular endothelial cells. (abstract) J Am Soc Nephrol 6:802, 1995
61. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin 1-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
62. COSTEROUSSE O, ALLEGRINI J, LOPEZ M, ALHENC-GELAS F: Angiotensin I converting enzyme in human circulatory mononuclear cells: Genetic polymorphism of expression in T lymphocytes. Biochem J 290:33-40, 1993
63. HUNLEY TE, JULIAN BA, PHILLIPS JA III. SUMMAR ML, YOSHIDA H, HORN RG, BROWN NJ, FOGO A, ICHIKAWA I, KON V: Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571-577, 1996
64. CAMBIEN F, POIRIER O, LECERF L, EVANS A, CAMBOU JP, ARVEILER D, LUC G, BARD JM, BARA L, RICARD S, TIRET L, AMOUYEL P, ALHENC-GELAS F, SOUBRIER F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
65. RAYNOLDS MV, BRISTOW MR, BUSH EW, ABRAHAM WT, LOWER BD, ZISMAN LS, TAFT CS, PERRYMAN MB: Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy, Lancet 342:1073-1075, 1993
66. EVANS AE, POIRIER O, KEE F: Polymorphisms of the angiotensin-converting-enzyme gene in subjects who died from coronary heart disease. Q J Med 87:211-214, 1994
67. BOHN M, BERGE KE, BAKKEN A, ERIKSSEN J, BERG K: Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet 44:292-297, 1993
68. BOHN M, BERGE KE, BAKKEN A, ERIKSSEN J, BERG K: Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet 44:298-301, 1993
69. LINDPAINTNER K, PFEFFER MA, KREUTZ R, STAMPFER MJ, GRODSTEIN F, LAMOTTE F, BURING J, HENNEKENS H: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemiC heart disease. N Engl J Med 332:706-711, 1995
70. TIERET L, BONNARDEAUX A, POIRIER O, MARQUES-VIDAL P, EVANS A, ARVEILER D, LUC G, KEE F, DUCIMETIERE P SOUBRIER F, CAMBIEN F: Synergistic effects of angiotensin-converting enzyme gene and angiotensin II type 1 receptor gene polymorphisms in risk of myocardial infarction. Lancet 344:910-913, 1992
71. BONNARDEAUX A, DAVIES E, JEUNEMAITRE X, FERY I, CHARRU A, CLAUSER E, TIRET L, CAMBIEN F, CORVOL P, SOUBRIER F: Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24:63-69, 1994
72. LUDWIG E, CORNELI PS, ANDERSON JL, MARSHALL HW, LALOUEL JM, WARD RH: Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 91:2120-2124, 1995
73. MARKUS HS, BARLEY J, LUNT R, BLAND JM, JEFFREY S, CARTER ND, BROWN MM: Angiotensin-converting enzyme gene deletion polymorphism: A new risk factor for lacunar stroke but not carotid atheroma. Stroke 26:1329-1333, 1995
74. MARIAN AJ, YU QT, WORKMAN R, GREVE G, ROBERTS R: Angiotensin-converting enzyme polymorphism in hypertrophie cardiomyopathy and sudden cardiac death. Lancet 342:1085-1086, 1993
75. SCHUNKERT H, HENSE H-W, HOLMER SR, STENDER M, PERZ S, KEIL U, LORELL BH, RIEGGER GAJ: Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638, 1994
76. OHISHI M, RAKUGI H, OGIHARA T: Association between a deletion polymorphism of the angiotensin converting-enzyme gene and left ventricular hypertrophy, (letter) N Engl J Med 331:1097-1098, 1994
77. KUPARI M, PEROLA M, KOSKINEN P, VIROLAINEN J, KARHUNEN PJ: Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 267:H1107-H1111, 1994
78. LINDPAINTNER K, LEE M, LARSON MG, RAO VS, PFEFFER MA, ORDOVAS JM, SCHAEFER EJ, WILSON AF, WILSON PWF, VASON RS, MYERS RH, LEVY D: Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 334:1023-1028, 1996
79. JEUNEMAITRE X, LIFTON RP, HUNT SC, WILLIAMS RR, LALOUEL JM: Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet 1:72-75, 1992
80. JEUNEMAITRE X, RIGAT B, CHARRU A, HOUOT AM, SOUBRIER F, CORVOL P: Sib pair linkage analysis of renin gene haplotypes in human essential hypertension. Hum Genet 88:301-306, 1992
81. JEUNEMAITRE X, SOUBRIER F, KOTELEVTSEV YV, LIFTON RP, WILLIAMS CS, CHARRU A, HUNT SC, HOPKINS PN, WILLIAMS RR, LALOUEL JM, CORVOL P: Molecular basis of human hypertension: Role of angiotensinogen. Cell 71:169-180, 1992
82. WATT GCM, HARRAP SB, FOY CJW, HOLTON DW, EDWARDS HV, DAVIDSON HR, CONNOR JM, LEVER AF, FRASER R: Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: A four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 10:473-482, 1992
83. KIM HS, KREGE JH, KLUCKMAN KD, HAGAMAN JR, HODGIN JB, BEST CF, JENNETTE JC, COFFMAN TM, MAEDA N, SMITHIES O: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 92:2735-2739, 1995
84. WARD K, HATA A, JEUNEMAITRE X, HELIN C, NELSON L, NAMIKAWA C, FARRINGTON PF, OGASAWARA M, SUZUMORI K, TOMODA S, BERREBI S, SASAKI M, CORVOL P, LIFTON RP, LALOUEL JM: A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 4:59-61, 1993
85. INOUE I, ANDREAS ROHRWASSER A, HELIN C, JEUNEMAITRE X, CRAIN P, BOHLENDER J, LIFTON RP, CORVOL P, WARD K, LALOUEL JM: A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. J Biol Chem 270:11430-11443, 1995
86. HAAS E, GOLDBLATT H: Kinetic constants of the human renin and human angiotensinogen reaction. Circ Res 20:45-55, 1967
87. PICKENS PT, BUMPUS FM, LLYOD AM, SMEBY RR, PAGE IH: Measurement of renin activity in human plasma. Circ Res 17:438-448, 1965
88. GOULD AB, GREEN D: Kinetics of the human renin and human substrate reaction. Cardiovasc Res 5:86-89, 1971
89. SLATER EE, STROUT HV JR: Pure human renin. Identification and characterization and of two majors molecur weight forms. J Biol Chem 256:8164-8171, 1981
90. ALLAN DR, Mc KNIGHT JA, KIFOR I, COLETTI CM, HOLLENBERG NK: Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 24:516-522, 1994
91. VAN Es LA: Pathogenesis of IgA nephropathy. Kidney int 41:1720-1729, 1992
92. GALLA JH: IgA nephropathy. Kidney Int 47:377-387, 1995
93. D'AMICO G: Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulo-nephritis: Survey of the recent literature. Am J Kidney Dis 20:315-323, 1992
94. COPPO R, AMORE A GIANOGLIO B, CACACE G, PICCIOTTO G, ROCCATELLO D, PERUZZI L, PICCOLI G, DE FILIPPI PG: Angiotensin local hyperactivity in the progression of IgA Nephropathv. Am J Kidney Dis 21:593-602, 1993
95. YOSHIDA H, MITARAI T, KAWAMURA T, KITAJIMA T, MIYAZAKI Y, NAGASAWA R, KAWAGUCHI Y, KUBO H, ICHIKAWA I, SAKAI O: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96:2162-2169, 1995
96. YORIOKA T, SUEHIRO T, YASUOKA N, HASHIMOTO K, KAWADA M: Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy. Clin Nephrol 44:80-85, 1995
97. HARDEN PN, GEDDES C, ROWE PA, MCILROY JH, BOULTON JONES M, ROGER RS, JUNOR BJ, BRIGGS JD, CONNELL JM, JARDINE AG: Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 345:1540-1542, 1995
98. MARRE M, BERNADET P, GALLOIS Y, SAVAGNER F, GUYENE TT, HALLAB M, CAMBIEN F, PASSA P, ALHENC GELAS F: Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388, 1994
99. FOGARTY DG, HUGHES AE, NEVIN NC, DOHERTY CC, MAXWELL AP: Functional genetic markers of the renin-angiotensin system and the risk of diabetic nephropathy in insulin dependent diabetes mellitus. (abstract) J Am Soc Nephrol 5:376, 1994
100. BARNAS U, SCHMIDTA, ILLIEVICH A, RABENSTEINER D, PRAGER R, MAYER G: The ACE gene polymorphism in patients with diabetic nephropathy. (abstract) J Am Soc Nephrol 6:1036, 1995
101. DORIA A, WARRAM JH, KROLEWSKI AS: Genetic predisposition to diabetic nephropathy: Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 43:690-695, 1994
102. TARNOW L, CAMBIEN F, ROSSING P, NIELSEN FS, HANSEN BV, LECERF L, POIRIER O, DANILOV S, PARVING HH: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-94, 1995
103. SCHMIDT S, SCHÖNE N, RITZ E: Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int 47:1176-1181, 1995
104. BILO HJG, THIJISSEN S, DE KNIJFF P, STEHOUWER CDA, KLUFT C: ACE and ANG gene polymorphism and diabetic nephropathy. (abstract) J Am Soc Nephrol 6:1037, 1995
105. MOGENSEN CE, SCHMITZ O: The diabetic kidney: From hyperfiltration and microalbuminuria to end-stage renal failure. Med Clin N Am 72:1465-1492, 1988
106. MOGENSEN CE: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31:673-689, 1987
107. PARVING H-H, GALL M-A, SKØTT P, JØRGENSEN HE, LØKKEGAARD H, JØRGENSEN F, NIELSEN B, LARSEN S: Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 41:758-762, 1992
108. TAFT JL, BILLSON VR, NANKERVIS A, KINCAID-SMITH P, MARTIN FI: A clinical-histologial study of individuals with diabetes mellitus and proteinuria. Diabetic Med 7:215-221, 1990
109. REMUZZI A, PERTICUCCI E, RUGGERIENTI P, MOSCONI L, LIMONTA M, REMUZZI G; Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 39:1267-1273, 1991
110. MASCHIO G, CAGNOLI L, CLARONI F, FUSAROLI M, RUGIU C, SANNA G, SASDELLI M, ZUCCALA A, ZUCCHELLI P: ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: A multi center, randomized, placebo-controlled study. Nephrol Dial Transplant 9:265-269, 1994
111. REKOLA S, BERGSTRAND A, BUCHT H: Deterioration rate in hypertensive IgA nephropathy: Comparison of a converting enzyme inhibitor and beta-blocking agents. Nephron 59:57-60, 1991
112. YOSHIDA H, KURIYMA S, ATSUMI Y, TOMONARI H, MITARAI T, HAMAGUCHI A, KUBO H, KAWAGUCHI Y, KON V, MATSUOKA K, ICHIKAWA I, SAKAI O: Accelerated course of progression to chronic renal failure in NIDDM patients with the deletion polymorphism of the angiotensin converting enzyme gene. Kidney Int (in press)
113. JACOBSON P, TARNOW L, ROSSING P, CAMBEIN F, LECERT L, POIRIER O, PARVING H-H: The insertion/deletion polymorphism in the angiotensin I converting enzyme gene predicts the progression of diabetic nephropathy during ACE inhibition in insulin dependent diabetic patients, (abstract) J Am Soc Nephrol 6:450, 1995
114. TARNOW L, ROSSING P, JACOBSEN P, NIELSEN FS, CAMBIEN F, LECERT L, POIRIER O, PARVING HH: Progression of diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-I-converting enzyme gene. (abstract) J Am Soc Nephrol 6:457, 1995
115. HARDEN PN, GEDDES C, BOULTON-JONES M, BRIGGS JD, JUNOR BJR, RIGER RSC, CONNELL JMC, JARDINE AG: Polymorphisms in the ACE gene in patients with renal disease. (abstract) J Am Soc Nephrol 5:330, 1994
116. VAN ESSEN GG, RENSMA PL, APPERLOO AJ, SCHEFFER H, SLUITER WJ, DE ZEEUW D, DE JONG PE: ACE-gene polymorphism predicts rate of loss of renal function in non-diabetic chronic renal failure. (abstract) J Am Soc Nephrol 6:407, 1995
117. FUKUSHIMA T, NOMURA S, KAWAI S, OSAWA G: ACE genotype and progression of IgA nephropathy. Lancet 346:571, 1995
118. SCHMIDT S, STIER E, HARTUNG R, STEIN G, BAHNISCH J, WOODROFFE AJ, CLARKSON AR, PONTICELLI C, CAMPISE M, MAYER G, GANTEN D, RITZ E: No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kid Dis 26:727-731, 1995
119. GACIONG ZA, RELIGA P, PLACHA G, RELL K, PACZEK L: ACE genotype and progression of IgA nephropathy. Lancet 346:570-571, 1995
120. NOMURA H, KONI I, MICHISHITA Y, MORISE T, TAKEDA R: Angiotensin converting enzyme gene polymorphism in hemodialysis patients. Lancet 343:482-483, 1994
121. SCHMIDT A, KIENER H, HAAS M, GRANINGER W, ARIAS E, MAYER G: Angiotensin converting enzyme (ACE) polymorphism in patients with terminal. (abstract) J Am Soc Nephrol 5:652, 1994
122. RUIZ J, BLANCHE H, COHEN N, VELHO G, CAMBIEN F, COHEN D, PASSA P, FROGUEL P: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetcs mellitus. Proc Natl Acad Sci USA 91:3662-3665, 1994
123. FOGARTY DG, HARRON JC, HUGHES AE, DOHERTY CC, MAXWELL AP: The association of an angiotensinogen gene variant with diabetic nephropathy. (abstract) J Am Soc Nephrol 6:449, 1995
124. SCHMIDT S, STROJEK K, GRZESZCZAK W, GANTEN D, RITZ E: The M235T variant of the angiotensinogen gene and nephropathy in Type 2 diabetes. (abstract) J Am Soc Nephrol 6:1047, 1995
125. HAMAGUCHI A, YOSHIDA H, HIYAZAKI Y, KAWAMURA T, MITARAI T, SAKAI O: The deletion polymorphism in the ACE gene is a risk factor for progression to renal failure independent of the M235T polymorphism in the angiotensinogen gene. (abstract) J Am Soc Nephrol 6:389, 1995
126. YOSHIDA H, HAMAGUCHI A, SHIMODA M, ETO T, KAWAMURA T, HUNLEY T, KON V, MITARAI T, SAKAI O: Does the A1166C polymorphism in the angiotensin type 1 receptor gene have an influence on the progression to renal failure? (abstract) J Am Soc Nephrol 6:409, 1995
127. TIRET L, RIGAT B, VISVIKIS S, BREDA C, CORVOL P, CAMBIEN F, SOUBRIER F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin-I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205, 1992
128. BJØRCK S, MULEC H, JOHSEN SA, NORDEN G, AURELL M: Renal protective effect of enalapril in diabetic nephropathy. Br Med J 304:339-343, 1992
129. OGURA M, YOSHIDA H, KAWAMURA T, HAMAGUCHI A, MIYAZAKI Y, MITARAI T, OKADA T, ETO T, KITAJIMA T, SAKAI O: The impact of the ACE gene polymorphism on the slowly progressive IgA nephropathy may be linked to the glomerular size. (abstract) J Am Soc Nephrol 6:398, 1995
130. YAMADA T, HORIUCHI M, MORISHITA R, ZHANG L, PRATT RE, DZAU VJ: In vivo identification of a negative regulatorY element in the mouse renin gene using direct gene transfer. J Clin Invest 96:1230-1237, 1995
131. BURT DW, NAKAMURA N, KELLEY P, DZAU VJ: Identification of negative and positive regulatory elements in the human renin gene. J Biol Chem 264:7357-7362, 1989
132. HAY N, TAKIMOTO M, BISHOP JM: A fos protein is present in a complex that binds a negative regulator of MYC. Gene Dev 3:293-303, 1989
133. BANIAHMAD A, MULLER M, STEINER C, RENKAWITZ R: Activity of two different silencer elements of the chicken lysozyme gene can be compensated by enhancer elements. Eur Mol Biol Organ 6:2297-2303, 1987
134. SAVAGNER P, MIYASHITA T, YAMADA Y: Two silencers regulate the tissue-specific expression of the collagen II gene. J Biol Chem 265:6669-6674, 1990
135. WINOTO A, BALTIMORE D: Alpha beta lineage-specific expression of the alpha T cell receptor gene by nearby silencers. Cell 59:649-655, 1989
136. MCKENZIE CA, JULILR C, FORRESTER T, MCFARLANE-ANDERSON N, KEAVNEY B, LATHROP GM, RATCLIFFE PJ, FARRALL M: Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: Evidence for two quantitative-trait loci. Am J Hum Genet 57:1426-1435, 1995
137. GANSEVOORT R, DE ZEEUW D, DE JONG PE: Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease. Am J Kid Dis 22:202-206, 1993